(Q44746359)

English

Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy

scientific article published in December 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 December 2017

Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy (English)

1 reference

Europe PubMed Central

5 December 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

Ilana Harman-Boehm

6

object named as

Ilana Harman-Boehm

1 reference

Europe PubMed Central

5 December 2017

author name string

Itamar Raz

1

1 reference

Europe PubMed Central

5 December 2017

Ulrik Mouritzen

2

1 reference

Europe PubMed Central

5 December 2017

Julius Vaz

3

1 reference

Europe PubMed Central

5 December 2017

Tommy Hershkovitz

4

1 reference

Europe PubMed Central

5 December 2017

Julio Wainstein

5

1 reference

Europe PubMed Central

5 December 2017

publication date

1 December 2003

1 reference

Europe PubMed Central

5 December 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

5 December 2017

25

1 reference

Europe PubMed Central

5 December 2017

12

1 reference

Europe PubMed Central

5 December 2017

3109-3123

1 reference

Europe PubMed Central

5 December 2017

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Postchallenge glucose concentration and coronary heart disease in men of Japanese ancestry. Honolulu Heart Program

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacologic therapy for type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacology of human insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved postprandial glycaemic controls with insulin Aspart in type 2 diabetic patients treated with insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients. UK Insulin Aspart Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and pharmacodynamics of a premixed formulation of soluble and protamine-retarded insulin aspart

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin aspart in a 30/70 premixed formulation. Pharmacodynamic properties of a rapid-acting insulin analog in stable mixture

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Twice-daily biphasic insulin aspart 30 versus biphasic human insulin 30: a double-blind crossover study in adults with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin Therapy in Obese, Non-insulin-dependent Diabetes Induces Improvements in Insulin Action and Secretion that Are Maintained for Two Weeks After Insulin Withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin treatment reverses the insulin resistance of type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingd

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

PPARS, insulin resistance and type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of insulin and thiazolidinedione therapy in massively obese patients with Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2990095-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(03)90095-6

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44746359&oldid=2036499143"